On Thursday, Uganda confirmed an outbreak of the Ebola virus in its capital city Kampala, with the first confirmed patient dying from it a day before. As per the new developments, the officials are now preparing to deploy a trial vaccine to put an end to this outbreak.
Groups of scientists are working on the vaccine and deployment of more than 2,000 doses of a candidate vaccine against the Sudan strain of Ebola has been planned and confirmed by the Uganda Virus Research Institute. As per the World Health Organization (WHO), Uganda has access to 2,169 doses of trial vaccine. For now, however, there are no approved vaccines for the strain and officials are still investigating the source of the outbreak.
The WHO had also allocated $1 million from its contingency fund for emergencies to support quick action and contain the outbreak in the country.
On Wednesday, the Sudan strain of Ebola killed a nurse employed at Kampala's main referral hospital. It is after his death that Ebola was declared an outbreak in the country. Post-mortem samples too have confirmed the Sudan Ebola Virus Disease and at least 44 contacts of the deceased man have been listed for tracing. 30 of these are health workers.
Ebola is a highly infectious hemorrhagic fever, which is transmitted through contact with bodily fluids and tissue. Symptoms include headache, vomiting of blood, muscle pains and bleeding.
it was in the late 2022, when Uganda had last suffered an Ebola outbreak. It killed 55 of the 143 people who were infected and was declared over on January 11, 2023.
As per the WHO, Ebola virus disease (EVD) is a rare but severe illness in humans and is often fatal. People can get infected with the virus if they touch an infected animal when preparing food, or touch body fluids of an infected person such as saliva, urine, faeces or semen, or things that have body fluids of an infected person like clothes or sheets.
Ebola enters the body through cuts in the skin or when one is touching their eyes, nose or mouth. Early symptoms include fever, fatigue and headache.
It was first discovered in 1976 in two simultaneous outbreak, when in Nzara, South Sudan and other in Yambuku, Democratic Republic of Congo. The latter occurred near a village near the Ebola River, which is where it gets its name from.
It is highly infectious and transmissible disease, in fact, there have been cases of health-care workers who have frequently been infected while treating patients with suspected or confirmed Ebola. This occurs through close contact with patients when infection control precautions are not practiced strictly.
Cases of people conducted burial ceremonies, involving direct contact with the body of the deceased too can lead to the transmission of Ebola. Even after the long suffering and recovery, there is a possibility of sexual transmission. Pregnant women who get acute Ebola and recover may still carry the virus in their breastmilk, or in pregnancy related fluids and tissues.
Credit: Instagram
Actress Shamita Shetty recently opened up about her endometriosis diagnosis as well as navigating perimenopause. It has sparked concerns about delayed detection of the condition and risks associated with it.
Speaking to Soha Ali Khan on her podcast All About Her alongside gynecological surgeon Dr. Neeta Warty, Shetty shared how her symptoms were dismissed repeatedly, leaving her searching for answers until the pain became unbearable and impossible to ignore.
She said that years of unexplained pain delayed her diagnosis, making her question whether what she was experiencing was simply a “normal” part of being a woman.
Shetty said routine medical tests initially failed to confirm the condition. As her health reports checked fine, she assumed her symptoms were ordinary, even as they kept returning.
“I wasn't given the right diagnosis initially,” Shetty said, explaining that she underwent standard gynecological examinations, including Pap smears, but no underlying cause was identified.
The actress said her symptoms intensified significantly in the months leading up to surgery. Although she considers herself to have a high pain tolerance due to previous injuries, she realized something was seriously wrong when the pain began waking her from sleep. After further investigations, she got diagnosed with endometriosis.
Shetty also revealed that she was entering perimenopause around the same time her symptoms of endometriosis worsened, making it difficult to distinguish between hormonal changes and signs of endometriosis.
Also read: World Population Day: How America's Falling Birth Rate Is Redefining Women's Healthcare?
Shetty underwent surgery for endometriosis in May 2024 and has since used her platform to encourage women not to ignore persistent pelvic pain.
During the podcast, she also addressed outdated advice that women with endometriosis should “have a baby” to solve the condition, recalling that one doctor suggested pregnancy as a treatment.
Shetty's diagnosis underscores the importance of paying attention to persistent symptoms rather than dismissing them as ordinary menstrual discomfort.
Severe period pain that disrupts daily activities, chronic pelvic pain, pain during intercourse, heavy menstrual bleeding, or difficulty becoming pregnant should be evaluated by a healthcare professional.
Also read: Beyond The Bump: Why Preconceptions And Antenatal Care Are Key To A Healthy Pregnancy
Endometriosis is a chronic condition in which tissue similar to the lining of the uterus grows outside the uterus. The condition often requires long-term management. It can cause symptoms like:
On the other hand, perimenopause, the transitional period before menopause, can bring symptoms such as irregular menstrual cycles, hot flashes, mood changes, sleep disturbances, and hormonal fluctuations.
If diagnosed late, endometriosis can lead to complications like:
According to the World Health Organization, endometriosis affects around 190 million women and girls worldwide, or 1 in 10 women of reproductive age.
The organization notes that many women experience diagnostic delays because symptoms are frequently normalized or mistaken for other conditions.
To curb this, the National Institute for Health and Care Excellence's (NICE) recently rolled out two non-invasive tests — the saliva-based Endotest and the gut sensor-based EndoSure — to help speed up the diagnosis of endometriosis in England and Wales.
Endotest analyses a saliva sample to identify tiny biological markers called microRNAs that can indicate whether endometriosis is likely to be present.
EndoSure is a non-invasive test that detects endometriosis by measuring electrical signals in the gut using sensor pads placed on the abdomen.
For this test, patients fast for six to eight hours before the test and drink water until full during the 45-minute procedure to help the device accurately record gut activity. Results are available immediately after the test.
Credit: iStock
A U.S. humanitarian worker in the Democratic Republic of the Congo (DRC) has tested positive for Ebola, raising fresh concerns as the country struggles with one of the worst Ebola outbreaks.
On Friday, the U.S. Centers for Disease Control and Prevention (CDC) confirmed, saying it is working closely with the individual's employer, U.S. government health agencies, and Congolese health authorities to prevent further transmission by tracing contacts to identify people who may have been exposed.
According to reports, the infected individual was working for a humanitarian organization in eastern Congo, where the outbreak has continued to spread despite ongoing response efforts.
The CDC has not released details about the patient's identity or condition but emphasized that contact tracing and public health measures are underway.
A spokesperson for the U.S. State Department said it is aware of the case and is assisting the affected American.
The spokesperson said, “A U.S. citizen working for a humanitarian organization in the Democratic Republic of the Congo has tested positive for the Bundibugyo strain of the Ebola virus. The CDC is working with the patient's employing organization, other federal agencies and partners in the Democratic Republic of the Congo to help prevent further transmission and identify high-risk contacts.”
The health regulatory body further said, “The risk of Ebola spreading in the United States remains low.”
The case comes as the Democratic Republic of the Congo faces an escalating Ebola crisis. According to the Africa CDC, the outbreak has now reached 1,830 confirmed cases and 648 deaths, making it the fastest-growing Ebola outbreak ever recorded on the continent. The outbreak was officially declared on May 15, 2026, and has spread across multiple provinces in eastern Congo.
Health officials say this outbreak is particularly concerning because it is caused by the Bundibugyo strain of the Ebola virus, a rare variant for which there is currently no approved vaccine or specific antiviral treatment.
The World Health Organization (WHO) has also warned that the official case count may significantly underestimate the true scale of the outbreak.
WHO modeling suggests that actual infections could be two to four times higher than reported because many cases are not being detected.
Nearly 80% of newly identified infections in some of the hardest-hit communities cannot be linked to known Ebola patients, indicating widespread community transmission.
The agency also reported that about 70% of deaths early in the outbreak occurred outside treatment centers, making surveillance and contact tracing even more difficult.
WHO Emergencies Director Chikwe Ihekweazu told Reuters, “Eighty percent of the new patients confirmed are coming outside of known contact lists” in Bunia, the epicenter of the outbreak, highlighting widespread undetected transmission.
He also warned, “The true scale of the outbreak is likely two to four times larger than the official figures suggest.”
The latest case highlights the dangers faced by frontline aid workers and underscores the urgency of strengthening outbreak control measures before the virus spreads further.
With no approved vaccine for the Bundibugyo strain and transmission continuing in several provinces, global health officials say rapid detection, isolation, and international cooperation remain essential to bringing the outbreak under control.
Credit: iStock
Health officials in England have confirmed that an adult with an underlying immunological condition has died from measles, marking the third measles-related death this year after two children died in June.
According to the latest figures from the UK Health Security Agency (UKHSA), England has recorded 883 confirmed measles cases between the start of the year and July 6. More than half of the cases have been reported in London, with most infections occurring in children aged 10 years and under.
All regions of England, including London (52 per cent), the West Midlands 17 per cent, and the North West 10 per cent, have now reported measles cases.
The UK was declared measles-free in 2017 but lost that status in 2019 after vaccination rates declined and outbreaks resumed.
In January, the World Health Organization (WHO) confirmed that the UK was no longer considered to have eliminated measles, citing stagnant vaccination coverage and rising case numbers.
Also read: Experts Say US Cyclospora Parasite Outbreak Is Unusual: How To Clean Fresh Produce
In response to the surge in infections, NHS leaders have launched a nationwide catch-up campaign targeting children aged two to 11 years who have missed one or both doses of the measles, mumps and rubella (MMR) vaccine.
The program will contact around one million families whose children are not fully vaccinated.
Current figures show that 84.1% of five-year-olds in England had received both doses of the MMR vaccine during the first three months of the year—well below the 95% coverage recommended to prevent outbreaks.
"We urge all parents to ensure their children are up to date with their MMR or MMRV vaccines, giving them the best and safest protection against measles," said Dr Vanessa Saliba, consultant epidemiologist at UKHSA.
"Anyone who has missed their measles vaccines can catch up through their GP practice, whatever their age. Getting vaccinated also helps protect babies who are too young to be vaccinated and people who cannot receive the vaccine because of certain health conditions," Dr Saliba added.
Read More: Crusted Scabies Outbreak: UK Reports Rare Highly Contagious Skin Disease
Measles (rubeola) is one of the world's most contagious viral infections. It spreads through respiratory droplets released when an infected person coughs or sneezes and can also spread by touching contaminated surfaces before touching the eyes, nose, or mouth.
Symptoms usually develop 7 to 14 days after exposure and include:
While many people recover fully, measles can cause serious complications, including pneumonia, encephalitis (brain inflammation), hearing loss, and, in rare cases, death.
The MMRV is a safe, live-attenuated immunizations that protect against severe viral infections. The shot combines Measles, Mumps, and Rubella, and also adds protection against Varicella (chickenpox).
According to the UKHSA, children receive:
Children who miss these doses can receive a catch-up vaccination at their 3-year and 4-month appointment. The MMRV vaccine contains weakened forms of the measles, mumps, rubella, and chickenpox viruses, which stimulate immunity without causing disease.
Two MMRV vaccines are available:
© 2024 Bennett, Coleman & Company Limited